Trademark Search  /  PROVIREX

PROVIREX

● Live · Registered

U.S. federal trademark · Serial No. 79270384 · Reg. No. 6087854

Mark
PROVIREX
Status
Registered
Serial Number
79270384
Registration No.
6087854
Filing Date
August 21, 2019
Registration Date
June 30, 2020
Class(es)
Class 001, Class 005, Class 042, Class 044

Owners

PROVIREX Genome Editing Therapies GmbH
99 · DE
Leibniz-Institut für Virologie
99 · DE
Heinrich-Pette-Institut, Leibniz-Institut für Experimentelle Virologie - Stiftung bürgerlichen Rechts
99 · Hamburg, DE
Heinrich-Pette-Institut, Leibniz-Institut für Experimentelle Virologie - Stiftung bürgerlichen Rechts
99 · Hamburg, DE

Goods & Services

Scientific and technological services, namely, scientific research in the field of virology; biological, biotechnological, clinical, medical and veterinary, pharmaceutical research and development; research in the field of gene therapy

Chemical substances for anti-viral use, chemical raw materials and chemical preparations in the form of powders, liquids or pastes; chemicals in the nature of anti-viral agents for use in the pharmaceutical industry; chemical compositions for use in science; biological preparations for use in industry and science; chemicals for industrial and scientific biotechnological purposes

Medical and veterinary preparations and articles, namely, medications and natural remedies in the nature of anti-viral medications; antiviral drugs for treating HIV; biological and biotechnological preparations for medical and veterinary purposes, in particular for treating HIV

Healthcare for human beings and animals, in particular for treating HIV; medical services featuring gene therapy; pharmaceutical compounding services; healthcare services, namely, clinical, medical, pharmaceutical and veterinary consultancy

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "PROVIREX" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.